| Literature DB >> 35409941 |
Hui-Mei Lin1,2, Chih-Kuang Liu2,3,4, Yen-Chun Huang2,3, Ming-Chih Chen2,3.
Abstract
BACKGROUND: Previous research mostly analyzed the utilization of palliative care for patients with cancer, and data regarding non-cancer inpatients are limited.Entities:
Keywords: machine learning methods; palliative care utilization
Mesh:
Year: 2022 PMID: 35409941 PMCID: PMC8998871 DOI: 10.3390/ijerph19074263
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Research flow chart of patients deceased between 1 January 2018 and 31 December 2018.
Baseline characteristics.
| Baseline | (%) | ||
|---|---|---|---|
| Overall population | 1668 | 100% | |
| Sex | Male | 916 | 54.92% |
| Female | 752 | 45.08% | |
| Age group | <65 | 225 | 13.49% |
| 65–79 | 440 | 26.38% | |
| ≥80 | 1003 | 60.13% | |
| Age (mean, std) | 80.32 (13.49) | ||
| DNR | Yes | 1332 | 79.86% |
| No | 336 | 20.14% | |
| Diagnosis | Cancer | 349 | 20.92% |
| Others | 1319 | 79.08% | |
| Hospital | Zhongxiao | 287 | 17.21% |
| Zhongxing | 243 | 14.57% | |
| Heping Fuyou | 347 | 20.80% | |
| Yangming | 221 | 13.25% | |
| Renai | 570 | 34.17% | |
| Family palliative care | Yes | 1226 | 73.50% |
| No | 442 | 26.50% | |
| Palliative consultation services | Yes | 377 | 22.60% |
| No | 1291 | 77.40% | |
| Palliative care units | Yes | 241 | 14.45% |
| No | 1427 | 85.55% | |
| Palliative care a | Yes | 497 | 29.80% |
| No | 1171 | 70.20% | |
| Length of stay (days) | 1–10 | 778 | 46.64% |
| 11–20 | 348 | 20.86% | |
| 21–30 | 219 | 13.13% | |
| >30 | 323 | 19.36% | |
| Length of stay (mean, std) | 27.30 (73.63) | ||
| TW-PCST score | (Mean, std) | 3.51 (2.16) | |
| Unknown ( | 378 | ||
| Medical expense, NTD | 194,818 (426,945) | ||
TW-PCST scores: Taiwanese version-palliative care screening tool scores; LOS: length of stay; a: The patients used either palliative consultation services or palliative care or both.
Inpatients at end of life with and without palliative care utilization.
| Baseline | Palliative Care | No Palliative Care |
| |||
|---|---|---|---|---|---|---|
| ( | ( | |||||
|
| % |
| % | |||
| Sex | Male | 237 | 47.69 | 515 | 43.98 | 0.1641 |
| Female | 260 | 52.31 | 656 | 56.02 | ||
| Age group | <65 | 61 | 12.27 | 164 | 14.01 | 0.5232 |
| 65–79 | 138 | 27.77 | 302 | 25.79 | ||
| ≥80 | 298 | 59.96 | 705 | 60.20 | ||
| Age mean (std) | 80.91 (13.12) | 80.07 (13.64) | 0.2453 | |||
| DNR | Yes | 406 | 81.69 | 926 | 79.08 | 0.2237 |
| No | 91 | 18.31 | 245 | 20.92 | ||
| Diagnosis | Cancer | 164 | 33.00 | 185 | 15.80 | ≤0.001 |
| Non-cancer | 333 | 67.00 | 986 | 84.20 | ||
| Hospital | Zhongxiao | 146 | 29.38 | 141 | 12.04 | ≤0.001 |
| Zhongxing | 86 | 17.30 | 157 | 13.41 | ||
| Heping Fuyou | 38 | 7.65 | 309 | 26.39 | ||
| Yangming | 7 | 1.41 | 214 | 18.27 | ||
| Renai | 220 | 44.27 | 350 | 29.89 | ||
| Family palliative care | Yes | 128 | 25.75 | 314 | 26.81 | 0.6536 |
| No | 369 | 74.25 | 857 | 73.19 | ||
| Length of stay (days) | 1–10 | 185 | 37.22 | 593 | 50.64 | ≤0.001 |
| 11–20 | 126 | 25.35 | 222 | 18.96 | ||
| 21–30 | 80 | 16.10 | 139 | 11.87 | ||
| >30 | 106 | 21.33 | 217 | 18.53 | ||
| TW-PCST score | (Mean, std) | 3.54 (2.13) | 3.50 (2.17) | 0.7459 | ||
| Unknown ( | 143 | 28.77 | 253 | 21.61 | 0.0312 | |
TW-PCST scores: Taiwanese version-palliative care screening tool scores; LOS: length of stay; SD: standard deviation.
Medical costs with and without palliative care.
| Baseline | Palliative Care | No Palliative Care |
| |
|---|---|---|---|---|
| Medical Cost, NTD | Medical Cost, NTD | |||
| ( | ( | |||
| Sex | Male | 195,004 (562,629) | 214,813 (445,634) | 0.6117 |
| Female | 154,594 (316,466) | 187,767 (362,371) | 0.2031 | |
| Age group | <65 | 176,236 (384,486) | 193,772 (301,040) | 0.7206 |
| 65–79 | 222,033 (680,109) | 209,985 (442,960) | 0.8492 | |
| ≥80 | 154,191 (333,399) | 202,019 (419,551) | 0.0557 | |
| DNR | Yes | 159,637 (320,538) | 192,234 (356,897) | 0.0995 |
| No | 247,553 (840,891) | 243,300 (570,642) | 0.9645 | |
| Diagnosis | Cancer | 91,527 (107,970) | 186,981 (427,035) | 0.0037 |
| Non-cancer | 217,206 (554,796) | 205,908 (408,255) | 0.7328 | |
| Family palliative care consultation | Yes | 197,256 (471,275) | 206,306 (344,590) | 0.7396 |
| No | 113,692 (429,506) | 193,673 (554,107) | 0.105 | |
| Length of stay mean (std) | 30.33 (81.60) | 26.02 (69.97) | 0.3046 | |
| TW-PCST score | (Mean, std) | 158,662 (331,716) | 189,907 (360,096) | 0.1557 |
| Unknown | 254,741 (37,115) | 217,887 (684,968) | 0.5738 | |
| Medical expense (std) | 175,734 (461,906) | 202,918 (411,150) | 0.2567 | |
| Average (Medical expense)/average (LOS) | 5789.1 (3855.4) | 12,115.8 (13,991.5) | ≤ 0.001 | |
Percentage utilization of two types of palliative care services.
| Hospital | Palliative Consultation Services | Palliative Care Units | ||
|---|---|---|---|---|
|
| % |
| % | |
| Renai | 79 | 30.86 | 141 | 55.83 |
| Zhongxiao | 46 | 17.97 | 100 | 44.17 |
| Zhongxing | 86 | 33.59 | – | |
| Heping Fuyou | 38 | 14.84 | – | |
| Yangming | 7 | 2.73 | – | |
–: No palliative care units in the hospital.
The value of coefficient by logistic regression model.
| Baseline | Estimate | Error | Pr (>Chi) |
|---|---|---|---|
| Intercept | −1.660 | 0.4372 | |
| Hospital | −0.2351 | 0.04925 | 0.01866 * |
| Sex | 0.130 | 0.1251 | 0.18719 |
| Age | 0.0059 | 0.0046 | 0.15969 |
| DNR | 0.2419 | 0.1618 | 0.18063 |
| Medical expense | −3.080 × 10−6 | 6.398 × 10−7 | <0.001 *** |
| Family palliative care consultation | 0.1030 | 0.1443 | 0.87391 |
| TW-PCST scores | 0.09851 | 0.01695 | <0.001 *** |
| LOS (days) | 0.01741 | 0.00351 | 0.24705 |
TW-PCST scores: Taiwanese version-palliative care screening tool scores; LOS: length of stay; *: p < 0.05; ***: p < 0.001.
Performance evaluation of prediction models.
| Accuracy | Kappa | Sensitivity | Specificity | AUC | |
|---|---|---|---|---|---|
| LGR | 0.6736 | 0.2673 | 0.8012 | 0.4625 | 0.7058 |
| CART | 0.6943 | 0.3495 | 0.8464 | 0.5213 | 0.7286 |
| MARS | 0.7510 | 0.4501 | 0.8692 | 0.5722 | 0.7847 |
| GB | 0.7357 | 0.4311 | 0.8865 | 0.5251 | 0.8213 |
LGR: logistic regression; CART: classification and regression tree; MARS: multivariate adaptive regression splines; GB: gradient boosting.